How should a dual‑energy X‑ray absorptiometry (DXA) scan be interpreted in patients with diabetes?

How to Read DXA Scans in Diabetes Patients

In patients with diabetes, DXA scans must be interpreted with heightened awareness that bone mineral density (BMD) underestimates fracture risk—standard T-score thresholds do not adequately capture the elevated fracture vulnerability in this population. 1, 2

Key Interpretation Principles for Diabetes

The Diabetes Paradox: Higher BMD, Higher Fracture Risk

Patients with type 2 diabetes typically demonstrate normal or even elevated BMD values compared to non-diabetic individuals (5.4%-7.7% higher), yet paradoxically face significantly increased fracture risk 3. This means:

• A T-score of -2.0 in diabetes patients should be interpreted as equivalent to -2.5 in non-diabetic patients 2
• Traditional T-score cutoffs underestimate fracture risk in diabetes
• Hip fracture risk is increased even at early disease stages despite normal or higher BMD 1

Standard DXA Interpretation Framework: PARED

Use the systematic PARED approach for all DXA interpretations 4:

• P (Positioning): Verify correct patient positioning
• A (Artifacts): Identify artifacts within regions of interest or soft tissue—critical in diabetes patients who may have constipation/fecal masses that falsely elevate BMD 5
• R (Regions of Interest): Confirm ROI placement is correct; ensure consistency on follow-up scans
• E (Edge Detection): Verify edge detection accuracy
• D (Demographics): Document patient demographics, diabetes status, duration, complications, and fracture risk factors 4

Measurement Sites and Technical Considerations

Required Measurement Sites

Perform DXA at lumbar spine (L1-L4), total hip, femoral neck, and if indicated, one-third radius 4. In diabetes patients:

• Lumbar spine measurements may be falsely elevated due to degenerative changes, vascular calcification, or artifacts 4
• Use the lowest T-score from any measured site for diagnosis 4
• Visual inspection of images is mandatory—do not rely solely on numeric data 5

Common Pitfalls in Diabetes

• Abdominal aortic calcification (AAC): Common in diabetes, can falsely elevate spine BMD
• Degenerative changes: More prevalent with longer diabetes duration
• Fecal masses: Can distort images and falsely elevate BMD 5
• Exclude vertebrae with fractures, focal structural changes, or overlying artifacts from analysis 4

Timing of DXA Screening in Diabetes

Type 2 Diabetes

Perform initial DXA scan at least 5 years after diabetes diagnosis in the absence of other comorbidities 1. However, consider earlier screening if:

• Poor glycemic control (HbA1c >9%)
• History of severe hypoglycemia
• Microvascular complications (nephropathy, retinopathy, neuropathy)
• Macrovascular disease
• Thiazolidinedione (TZD) use in women
• Frequent falls
• Disease duration >10 years

Reassess every 2-3 years depending on initial findings and additional risk factors 1

Type 1 Diabetes

Consider BMD assessment after age 50, as hip fracture risk increases after the 5th decade 1. BMD significantly underestimates fracture risk in type 1 diabetes, though the exact degree of underestimation is unclear.

Additional Assessment Tools

Trabecular Bone Score (TBS)

TBS is reduced in type 2 diabetes independent of aBMD, providing additional fracture risk information 6. However:

• TBS shows limitations in both type 1 and type 2 diabetes 6
• Negative predictors: BMI and P1NP 3
• Positive predictor: CTX 3

Vertebral Fracture Assessment (VFA)

Perform VFA or standard radiography in diabetes patients ≥50 years with 4:

• T-score < -1.0 (note: lower threshold than non-diabetic patients)
• Historical height loss >4 cm
• Self-reported vertebral fracture
• Long-term glucocorticoid therapy (≥5 mg prednisone equivalent daily for ≥3 months)

Bone Turnover Markers

Bone turnover markers are suppressed in diabetes and have NOT been shown to predict fracture risk—do not rely on them for clinical decision-making 1

Fracture Risk Factors Requiring Documentation

Document these diabetes-specific risk factors that amplify fracture risk 1:

• Glycemic control: Each 1% increase in HbA1c = 8% increased fracture risk
• Hypoglycemia history: Increases fracture risk by 52%
• Disease duration: >10 years for type 2, >26 years for type 1
• Microvascular complications: Nephropathy, retinopathy, neuropathy
• Cardiovascular disease
• Medication history: TZD use (doubles fracture risk in women after 1-2 years)

Diagnostic Thresholds

Osteoporosis diagnosis: T-score ≤ -2.5 at lumbar spine, femoral neck, total hip, or one-third radius using NHANES III reference database 4

However, in diabetes patients, consider treatment at higher T-score thresholds given the BMD-fracture risk discordance 2

Fragility fracture = osteoporosis diagnosis regardless of DXA values 1

Reporting Requirements

Include in every DXA report 4:

• Patient demographics including diabetes status and duration
• Manufacturer/model/software version
• Technical quality and limitations
• BMD (g/cm²) and T-scores for each site
• Diabetes-specific risk factors (glycemic control, hypoglycemia, complications, medications)
• FRAX scores (if applicable)
• Diagnosis
• Treatment recommendations
• Follow-up interval (typically 2-3 years in diabetes)

Critical Clinical Caveat

The increased fracture risk in diabetes is NOT sufficiently explained by T-score alone 2. Clinical judgment incorporating diabetes duration, complications, glycemic control, and hypoglycemia history is essential for accurate fracture risk assessment and treatment decisions. When in doubt, treat more aggressively than BMD values alone would suggest.